$Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.$

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.

Recent studies have suggested that alveolar nitric oxide (NO) concentration is a noninvasive test of distal lung inflammation. The current study determined whether alveolar NO concentration can be measured in patients with asthma of varying severity, tested the hypothesis that there is an associatio...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Berry, M, Hargadon, B, Morgan, A, Shelley, M, Richter, J, Shaw, D, Green, R, Brightling, C, Wardlaw, A, Pavord, I
التنسيق:	Journal article
اللغة:	English
منشور في:	2005

مواد مشابهة

Evidence of a role of tumor necrosis factor alpha in refractory asthma.
حسب: Berry, M, وآخرون
منشور في: (2006)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
حسب: Shaw, D, وآخرون
منشور في: (2007)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
حسب: Berry, M, وآخرون
منشور في: (2005)

The significance of eosinophilic airway inflammation in asthma
حسب: Pavord, I, وآخرون
منشور في: (2002)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
حسب: Haldar, P, وآخرون
منشور في: (2009)

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.
حسب: Shaw, D, وآخرون
منشور في: (2007)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
حسب: Bilocca, D, وآخرون
منشور في: (2017)

TNF-alpha in asthma.
حسب: Berry, M, وآخرون
منشور في: (2007)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
حسب: Bafadhel, M, وآخرون
منشور في: (2010)

New insights into the relationship between airway inflammation and asthma.
حسب: Wardlaw, A, وآخرون
منشور في: (2002)

Cluster analysis and clinical asthma phenotypes.
حسب: Haldar, P, وآخرون
منشور في: (2008)

Mepolizumab in refractory eosinophilic asthma.
حسب: Pavord, I, وآخرون
منشور في: (2010)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
حسب: Berry, M, وآخرون
منشور في: (2007)

Management of asthma in adults: current therapy and future directions.
حسب: Green, R, وآخرون
منشور في: (2003)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
حسب: Green, R, وآخرون
منشور في: (2002)

Eosinophils in asthma and other allergic diseases.
حسب: Wardlaw, A, وآخرون
منشور في: (2000)

Exacerbations of severe asthma in patients treated with mepolizumab
حسب: Shrimanker, R, وآخرون
منشور في: (2018)

Cough and asthma.
حسب: Berry, M, وآخرون
منشور في: (2003)

Non-eosinophilic corticosteroid unresponsive asthma.
حسب: Pavord, I, وآخرون
منشور في: (1999)

The use of exhaled nitric oxide in the management of asthma.
حسب: Pavord, I, وآخرون
منشور في: (2008)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
حسب: Green, R, وآخرون
منشور في: (2006)

New insights into the role of the mast cell in asthma.
حسب: Brightling, C, وآخرون
منشور في: (2003)

Antagonism of tumour necrosis factor alpha in refractory asthma.
حسب: Berry, M, وآخرون
منشور في: (2008)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
حسب: Shaw, D, وآخرون
منشور في: (2012)

CRTH2 expression on T cells in asthma.
حسب: Mutalithas, K, وآخرون
منشور في: (2010)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
حسب: Brightling, C, وآخرون
منشور في: (2003)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
حسب: Brightling, C, وآخرون
منشور في: (1999)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
حسب: Kulkarni, N, وآخرون
منشور في: (2010)

A comparison of the validity of different diagnostic tests in adults with asthma.
حسب: Hunter, C, وآخرون
منشور في: (2002)

Biomarkers predicting response to corticosteroid therapy in asthma.
حسب: Brightling, C, وآخرون
منشور في: (2005)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
حسب: Haldar, P, وآخرون
منشور في: (2014)

Mast-cell infiltration of airway smooth muscle in asthma.
حسب: Brightling, C, وآخرون
منشور في: (2002)

The relationship between clinical outcomes and medication adherence in difficult-to-control asthma.
حسب: Murphy, A, وآخرون
منشور في: (2012)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
حسب: Haldar, P, وآخرون
منشور في: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
حسب: Haldar, P, وآخرون
منشور في: (2014)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
حسب: Berry, M, وآخرون
منشور في: (2004)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
حسب: Saha, S, وآخرون
منشور في: (2008)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
حسب: Fairs, A, وآخرون
منشور في: (2010)

Eosinophils in asthma and airway hyperresponsiveness.
حسب: Brightling, C, وآخرون
منشور في: (2004)

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study.
حسب: Wilson, E, وآخرون
منشور في: (2014)